Colorectal Cancer Quality Metrics

Commission on Cancer's Quality of Care Measures

UC San Diego Health's cancer program is accredited by the Commission on Cancer (CoC), which collects standardized data from CoC-accredited health care settings to measure cancer care quality.

The data presented below is included in the CoC's quality of care measures for colon and rectal cancer, and are for 2014, the most recent year for which data is available. (Data provided by the National Cancer Database.)

The purpose of the data is to compare the care of colorectal cancer patients at UC San Diego Health with other CoC-accredited cancer programs regionally and nationwide. UC San Diego's results compare favorably in all below measures. For more information about quality and safety measures, see Quality Care.

Adjuvant chemotherapy considered within four months of diagnosis with AJCC Stage III (lymph node positive) colon cancer (when appropriate)

UC San Diego Health93.3%
State of California81.0%
Pacific Region84.6%
Teaching Hospitals89.2%
All Commission on Cancer Approved Programs89.0%


At least 12 regional lymph nodes removed and examined for resected colon cancer

UC San Diego Health100%
State of California89.9%
Pacific Region91.1%
Teaching Hospitals92.2%
All Commission on Cancer Approved Programs91.3%


Radiation therapy considered within six months of diagnosis for AJCC T4N0M0 or Stage III receiving surgical resection for rectal cancer

UC San Diego Health94.4%
State of California89.3%
Pacific Region89.8%
Teaching Hospitals89.0%
All Commission on Cancer Approved Programs89.1%


Appointments & Referrals


La Jolla

Meet Our Specialists